Article
Identification of new candidate drugs for primary Sjögren’s syndrome using a drug repurposing transcriptomic approach
2 Mar 2023
Abstract excerpt
OBJECTIVES: To date, no immunomodulatory drug has demonstrated its efficacy in primary SS (pSS). We sought to analyse potential commonalities between pSS transcriptomic signatures and signatures of various drugs or specific knock-in or knock-down genes. METHODS: Gene expression from peripheral blood samples of patients with pSS was compared with that of healthy controls in two cohorts and three public databases....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
